Casi Pharmaceuticals Inc (CASI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.43 +0.17 (+7.52%) 03/18/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.43 unch (unch) 16:00 ET
for Tue, Mar 18th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CASI | RVPH | NRXP | ||
| Company | Casi Pharmaceuticals Inc | Reviva Pharmaceuticals Hldg Inc | Nrx Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.25 | 1.1200 | 2.03 | ||
| High | 2.48 | 1.1300 | 2.22 | ||
| Low | 2.23 | 1.0800 | 2.03 | ||
| Last | 2.43 | 1.0800 | 2.20 | ||
| Change | +0.17 | -0.0200 | +0.15 | ||
| % Change | +7.52% | -1.82% | +7.32% | ||
| Volume | 13,500 | 408,300 | 186,200 | ||
| 20-Day Average Volume | 7,150 | 966,150 | 228,655 | ||
| Previous Close | 2.26 | 1.1000 | 2.05 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.30 | 1.2970 | 2.23 | ||
| 20-Day Raw Stochastic | 81.15% | 5.01% | 36.78% | ||
| 20-Day Relative Strength | 48.50% | 34.51% | 45.96% | ||
| Weighted Alpha | -45.47 | -63.46 | -74.62 | ||
| Today's Opinion | 80% Sell | 40% Sell | 32% Buy | ||
| Previous Opinion | 100% Sell | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 100% Sell | 64% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.95% since 03/11/25 | -6.90% since 03/11/25 | +3.77% since 03/11/25 | ||
| Low | 2.04 on 03/14/25 | 1.0400 on 03/13/25 | 1.98 on 03/13/25 | ||
| High | 2.48 on 03/18/25 | 1.2250 on 03/12/25 | 2.41 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | -3.76% since 02/18/25 | -41.30% since 02/18/25 | -19.12% since 02/18/25 | ||
| Low | 2.04 on 03/14/25 | 1.0400 on 03/13/25 | 1.84 on 03/03/25 | ||
| High | 2.52 on 02/19/25 | 1.8391 on 02/19/25 | 2.82 on 02/19/25 | ||
| 3-Month | |||||
| %Chg | -15.03% since 12/18/24 | -24.48% since 12/18/24 | +42.39% since 12/18/24 | ||
| Low | 2.04 on 03/14/25 | 1.0400 on 03/13/25 | 1.40 on 12/23/24 | ||
| High | 3.47 on 12/26/24 | 2.1700 on 01/07/25 | 6.01 on 01/13/25 | ||
| 6-Month | |||||
| %Chg | -64.05% since 09/18/24 | -21.74% since 09/18/24 | +35.80% since 09/18/24 | ||
| Low | 2.04 on 03/14/25 | 0.8820 on 11/11/24 | 1.10 on 10/16/24 | ||
| High | 7.50 on 10/09/24 | 4.2800 on 12/09/24 | 6.01 on 01/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,014 | 36,785 | 34,678 | ||
| Shares Outstanding, K | 15,493 | 33,441 | 16,916 | ||
| Annual Sales | 33,880,000 | 0 | 0 | ||
| Annual Net Income | -26,940,000 | -39,260,000 | -25,130,000 | ||
| Last Quarter Sales | 7,790,000 | 0 | 0 | ||
| Last Quarter Net Income | -8,400,000 | -8,370,000 | -9,080,000 | ||
| 60-Month Beta | 0.41 | -0.09 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/15/24 | -0.25 on 11/14/24 | -0.15 on 11/14/24 | ||
| Latest Earnings Date | 03/27/25 | 04/21/25 | 03/17/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||